BlackRock, Inc. - Sep 30, 2025 SCHEDULE 13G/A Report for Lexeo Therapeutics, Inc. Common Stock (LXEO)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: Lexeo Therapeutics, Inc. Common Stock
Symbol: LXEO
Shares outstanding: 54.2M shares
Disclosed Ownership: 2.17M shares
Ownership: 4%
Form type: SCHEDULE 13G/A
Date filed: 10/17/2025, 06:13 PM
Date of event: Sep 30, 2025
Previous filing: Feb 4, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	4%	2.17M	2.13M	0	Spencer Fleming	Managing Director